Cipla has achieved global renown primarily due to its historic role in pioneering affordable access to life-saving medications, most notably when it broke international pricing barriers in the early two thousands by supplying low-cost antiretroviral therapies to treat HIV and AIDS across developing nations. Founded decades earlier with a strong nationalistic vision to make healthcare self-reliant, the company transformed into a massive multinational pharmaceutical enterprise recognized for its extensive portfolio of high-quality generic drugs and advanced respiratory delivery systems. Its continuous commitment to manufacturing essential medicines at a fraction of standard market costs has solidified its reputation globally as a champion of public health equity and affordable pharmaceutical accessibility.